Quick Answer
BioScience Health Innovations, Inc. reported Stockholders Equity of $1.48 million for fiscal year 2025.
BioScience Health Innovations, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $1.48M | +76.9% |
| 2024 | $835.2K | +12455.6% |
| 2023 | -$6.8K | +60.7% |
| 2022 | -$17.2K | -219.4% |
| 2022 | $14.4K | +1527.9% |
| 2021 | -$1.0K | +92.1% |
| 2021 | -$12.8K | -199.8% |
| 2020 | $12.8K | +574.6% |
| 2019 | $1.9K | — |
| 2019 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.71M | +362.1% | -0.5% |
| June 30, 2025 | $1.72M | +809.5% | +36.3% |
| March 31, 2025 | $1.26M | +998.8% | +51.1% |
| December 31, 2024 | $835.2K | +12455.6% | +125.6% |
| September 30, 2024 | $370.3K | +4204.6% | +95.8% |
| June 30, 2024 | $189.1K | +448.5% | +64.6% |
| March 31, 2024 | $114.9K | +229.1% | +1799.1% |
| December 31, 2023 | -$6.8K | — | -178.6% |
- BioScience Health Innovations, Inc. showed an increase of +76.9% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from BioScience Health Innovations, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: